e-Drug3D

1798

LEUCOMETHYLENE BLUE


INN
LEUCOMETHYLENE BLUE

(is an active metabolite)

cas 613-11-6
CLASS

TREATMENT OF METHEMOGLOBINEMIA
AN OXIDATION-REDUCTION AGENT
PROMOTES A NON-ENYZMATIC REDOX CONVERSION OF METHB TO HEMOGLOBIN
CONVERTED INTO LEUCOMETHYLENE BLUE (LMB) BY NADPH REDUCTASE

ROUTE (list)

-

ATC code

V03AB17
V04CG05

PK parameters

Target

TARGET HEMOGLOBIN IRON

DrugCentral

-

Download SDF file 10H-Phenothiazine-3,7-diamine, N3,N3,N7,N7-tetramethyl-

Formula:
C16H19N3S

Calculated chemical properties:

MW 285.41
NB_atoms 20
XLogP 4.03
PSA 19.981
NB_HD 1
NB_HA 3
fsp3 0.25
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL